Clinical Trials Directory

Trials / Terminated

TerminatedNCT02795975

Clinical Evaluation of the Aptima® Combo 2® Assay Using the Panther® System in Female Urine Samples

Status
Terminated
Phase
Study type
Observational
Enrollment
1,766 (actual)
Sponsor
Hologic, Inc. · Industry
Sex
Female
Age
14 Years
Healthy volunteers
Accepted

Summary

The objective of this study is to evaluate the performance characteristics of the AC2 assay on the Panther system using female urine specimens.

Conditions

Timeline

Start date
2016-06-30
Primary completion
2017-03-01
Completion
2017-03-01
First posted
2016-06-10
Last updated
2017-03-24

Locations

18 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02795975. Inclusion in this directory is not an endorsement.